JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...
Children’s Hospital of The King’s Daughters is suspending hormone therapy and puberty blocker treatments used as gender-affirming care for patients under 19 years old after an ...
In a ceremony chock-full of talent, queer artists won big at Music's Biggest Night and stood defiant in the face of right-wing politicians aiming to litigate their existence.
Evangelical ethicists and advocates say the administration’s moves are “desperately needed” to combat the growing acceptance of trans identity and treatments at younger ages.